William G. Wright

Array ( [id] => 9932163 [patent_doc_number] => 20150080355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'Pharmaceutical Compositions Comprising Ebastine and Fluticasone' [patent_app_type] => utility [patent_app_number] => 14/235874 [patent_app_country] => US [patent_app_date] => 2012-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10258 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14235874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9269712 [patent_doc_number] => 20140024630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'METHOD FOR THE NON-SURGICAL TREATMENT OF LIPODYSTROPHY IN A RETROVIRUS-INFECTED INDIVIDUAL' [patent_app_type] => utility [patent_app_number] => 13/553066 [patent_app_country] => US [patent_app_date] => 2012-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2153 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13553066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9757336 [patent_doc_number] => 20140288037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'NOVEL COMPOSITIONS AND METHODS FOR TREATING PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 14/233335 [patent_app_country] => US [patent_app_date] => 2012-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 24993 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8927609 [patent_doc_number] => 20130183369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'Means of inducing cellular exocytosis and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/548006 [patent_app_country] => US [patent_app_date] => 2012-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3455 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13548006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9721073 [patent_doc_number] => 20140256774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'METHODS FOR TREATING INFLAMMATION AND HYPERTENSION WITH GAMMA-KETOALDEHYDE SKAVENGERS' [patent_app_type] => utility [patent_app_number] => 14/232615 [patent_app_country] => US [patent_app_date] => 2012-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13995 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14232615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9670481 [patent_doc_number] => 20140234345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'NOVEL ANTI-CANCER ISOCARBOSTYRIL ALKALOID CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/131950 [patent_app_country] => US [patent_app_date] => 2012-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8485 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14131950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10975472 [patent_doc_number] => 20140378507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'VITAMIN D RECEPTOR AGONISTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/232196 [patent_app_country] => US [patent_app_date] => 2012-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11763 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14232196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465738 [patent_doc_number] => 20120270907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'THERAPEUTIC USES OF NICOTINE' [patent_app_type] => utility [patent_app_number] => 13/534710 [patent_app_country] => US [patent_app_date] => 2012-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3832 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13534710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10560653 [patent_doc_number] => 09284312 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-15 [patent_title] => 'N-methyl tetrahydroquinoline M1 receptor positive allosteric modulators' [patent_app_type] => utility [patent_app_number] => 14/117178 [patent_app_country] => US [patent_app_date] => 2012-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19426 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8866895 [patent_doc_number] => 20130150598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'USE OF 25-HYDROXY-VITAMIN D3 TO AFFECT HUMAN MUSCLE PHYSIOLOGY' [patent_app_type] => utility [patent_app_number] => 13/467414 [patent_app_country] => US [patent_app_date] => 2012-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9857 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9339741 [patent_doc_number] => 20140066523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'Drug Delivery Compositions And Methods Of Use' [patent_app_type] => utility [patent_app_number] => 14/115219 [patent_app_country] => US [patent_app_date] => 2012-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31156 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14115219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9435980 [patent_doc_number] => 20140113887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-24 [patent_title] => 'COMPOSITION FOR TOPICAL APPLICATION FOR PREVENTING HAIR LOSS AND STIMULATING HAIR GROWTH' [patent_app_type] => utility [patent_app_number] => 14/114185 [patent_app_country] => US [patent_app_date] => 2012-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6827 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8417647 [patent_doc_number] => 20120245147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'INHIBITORS OF THAPSIGARGIN-INDUCED CELL DEATH' [patent_app_type] => utility [patent_app_number] => 13/451187 [patent_app_country] => US [patent_app_date] => 2012-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 26157 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13451187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9448918 [patent_doc_number] => 20140120087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'TRIAZOLOPYRIDINES' [patent_app_type] => utility [patent_app_number] => 14/113017 [patent_app_country] => US [patent_app_date] => 2012-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71383 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9839573 [patent_doc_number] => 20150031655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'COMBINATION OF LIVER X RECEPTOR MODULATOR AND ESTROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF AGE-RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 14/111916 [patent_app_country] => US [patent_app_date] => 2012-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22073 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10154629 [patent_doc_number] => 09186381 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'Medicament for liver regeneration and for treatment of liver failure' [patent_app_type] => utility [patent_app_number] => 14/009738 [patent_app_country] => US [patent_app_date] => 2012-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 17 [patent_no_of_words] => 9992 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10209353 [patent_doc_number] => 20150094344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'SHORT-ACTING DIHYDROPYRIDINES (CLEVIDIPINE) FOR USE IN REDUCING STROKE DAMAGE' [patent_app_type] => utility [patent_app_number] => 14/009212 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3889 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9295413 [patent_doc_number] => 20140039047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'METHODS FOR REGULATING SIRTUIN GENE EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/111617 [patent_app_country] => US [patent_app_date] => 2012-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7746 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9212716 [patent_doc_number] => 20140011893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'COMPOSITION AND METHOD' [patent_app_type] => utility [patent_app_number] => 14/006701 [patent_app_country] => US [patent_app_date] => 2012-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10953 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15160615 [patent_doc_number] => 10485780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-26 [patent_title] => Methods and compositions for the treatment of proliferative disorders [patent_app_type] => utility [patent_app_number] => 14/004759 [patent_app_country] => US [patent_app_date] => 2012-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 16 [patent_no_of_words] => 14669 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004759 [rel_patent_id] =>[rel_patent_doc_number] =>)